DC-CPin711
DC-CPin711 is a potent and selective inhibitor of CREB-binding protein (CBP) bromodomain with an IC50 of 0.0626 μM. DC-CPin711 arrests cell cycle at G1 phase and induces apoptosis[1].
Product Specifications
CAS Number
2447559-21-7
UNSPSC
12352005
Target
Apoptosis; Epigenetic Reader Domain
Type
Reference compound
Related Pathways
Apoptosis; Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/dc-cpin711.html
Purity
99.09
Solubility
10 mM in DMSO
Smiles
O=C(N1CCCC2=C1C=C(NC(C3=CC=CC(C4=CC=NC=C4)=C3)=O)C=C2)NC
Molecular Formula
C23H22N4O2
Molecular Weight
386.45
References & Citations
[1]Chen Y, et al. Design, synthesis, and biological evaluation of tetrahydroquinolin derivatives as potent inhibitors of CBP bromodomain. Bioorg Chem. 2020 Aug;101:103991.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC741646-500 1x 500 µL
CD99 / MIC2 (Ewing's Sarcoma Marker), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNCB0580-500 1x 500 µL
Histone H1 (1415-1), Biotin conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
